BioLineRX Ltd. (NASDAQ:BLRX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Barbara-Jean Anne Bormann-Kennedy Other companies: Xeris Biopharma Holdings, Inc. (Director · Since at least Oct 5, 2021); BetterLife Pharma Inc. (President, Director · Feb 5, 2015 – Feb 5, 2015 · Past) | Director · Since at least Mar 18, 2026 |
| Aharon Schwartz Other companies: Protalix BioTherapeutics, Inc. (de) (Director · Since at least Nov 10, 2014) | Director · Since at least Mar 18, 2026 |
| BJ Bormann Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Nov 5, 2026) | BOARD MEMBER · Since at least Nov 6, 2026 |
| Philip A Serlin Other companies: XWELL, Inc. (Director · Feb 15, 2012 – Mar 13, 2012 · Past) | Chief Executive Officer · Since at least Mar 18, 2026 |
| Raphael Hofstein Other companies: Scopus BioPharma, Inc. (Director · Dec 16, 2020 – Dec 16, 2020 · Past) | Director · Since at least Mar 18, 2026 |
| Avraham Molcho | BOARD MEMBER · Since at least Mar 18, 2026 |
| Bela Neiman | VICE PRESIDENT, ANALYTICAL CHEMISTRY · Since at least Nov 6, 2026 |
| Efrat Halbfinger | VICE PRESIDENT, CHEMISTRY AND FORMULATION · Since at least Nov 6, 2026 |
| Ella Sorani | CHIEF DEVELOPMENT OFFICER · Since at least Nov 6, 2026 |
| Gal Cohen | BOARD MEMBER · Since at least Mar 18, 2026 |
| Irit Gliko-Kabir | VICE PRESIDENT, CLINICAL OPERATIONS · Since at least Nov 6, 2026 |
| Jael Birenberg | VICE PRESIDENT, REGULATORY AFFAIRS, QUALITY ASSURANCE & PHARMACOVIGILANCE · Since at least Nov 6, 2026 |
| Mali Zeevi | CHIEF FINANCIAL OFFICER · Since at least Mar 18, 2026 |
| Philip A. Serlin | CHIEF EXECUTIVE OFFICER · Since at least Sep 10, 2026 |
| Rafael Hofstein | BOARD MEMBER · Since at least Nov 6, 2026 |
| Rami Dar | BOARD MEMBER · Since at least Mar 18, 2026 |
| Sandra Panem | BOARD MEMBER · Since at least Mar 18, 2026 |
| Shaoyu Yan | BOARD MEMBER · Since at least Mar 18, 2026 |